Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2026-03-08 @ 5:07 AM
Study NCT ID:
NCT05283694
Status:
COMPLETED
Last Update Posted:
2022-03-17
First Post:
2022-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Bioavailability of Risankizumab Following Subcutaneous Dosing in Healthy Male Participants
Sponsor:
Organization: